Business Standard

GVK Bio partners US firm

Related News

Hyderabad-based drug discovery research and development firm (GVK Bio) has entered into a collaboration agreement with US-based Endo Pharmaceuticals focused on discovering novel small molecules targeting a protein.

As per the agreement, GVK Bio will use its discovery expertise to deliver a clinical candidate and Endo will develop and commercialise the product arising out of this collaboration. The collaboration arose out of a newly-launched concept at GVK Bio named Early Discovery Assets (EDA).

Read more on:   
|
|

GVK Bio partners US firm

Hyderabad-based drug discovery research and development firm GVK Biosciences (GVK Bio) has entered into a collaboration agreement with US-based Endo Pharmaceuticals focused on discovering novel small molecules targeting a protein.

Hyderabad-based drug discovery research and development firm (GVK Bio) has entered into a collaboration agreement with US-based Endo Pharmaceuticals focused on discovering novel small molecules targeting a protein.

As per the agreement, GVK Bio will use its discovery expertise to deliver a clinical candidate and Endo will develop and commercialise the product arising out of this collaboration. The collaboration arose out of a newly-launched concept at GVK Bio named Early Discovery Assets (EDA).

image

Read More

OIL, OVL eye SE Africa assets

Oil India Ltd (OIL) and ONGC Videsh Limited (OVL), the foreign arm of Oil and Natural Gas Corp, will make a joint bid to acquire a 10 per cent stake ...

Recommended for you

Quick Links

Back to Top